12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga · 4d ago
Gainers
- Alvotech (NASDAQ:ALVO) shares increased by 17.4% to $9.32 during Wednesday's after-market session. The market value of their outstanding shares is at $2.8 billion. As per the press release, Q1 earnings came out today.
- Generation Bio (NASDAQ:GBIO) stock increased by 15.38% to $0.45. The company's market cap stands at $30.1 million. As per the press release, Q1 earnings came out today.
- Revolution Medicines (NASDAQ:RVMD) stock increased by 12.9% to $42.52. The company's market cap stands at $7.9 billion. The company's, Q1 earnings came out today.
- GoodRx Holdings (NASDAQ:GDRX) stock increased by 8.97% to $4.13. The market value of their outstanding shares is at $1.4 billion. As per the press release, Q1 earnings came out today.
- CARISMA Therapeutics (NASDAQ:CARM) shares increased by 8.79% to $0.23. The company's market cap stands at $9.7 million.
- Emergent BioSolutions (NYSE:EBS) stock increased by 8.43% to $5.14. The company's market cap stands at $279.2 million. The company's, Q1 earnings came out today.
Losers
- NuCana (NASDAQ:NCNA) shares decreased by 70.2% to $0.09 during Wednesday's after-market session.
- electroCore (NASDAQ:ECOR) stock decreased by 14.08% to $5.85. The market value of their outstanding shares is at $42.0 million. The company's, Q1 earnings came out today.
- LogicMark (NASDAQ:LGMK) stock fell 13.98% to $0.01.
- Exagen (NASDAQ:XGN) stock declined by 13.47% to $5.91. The company's market cap stands at $105.7 million. The company's, Q1 earnings came out 2 days ago.
- Staar Surgical (NASDAQ:STAA) stock decreased by 12.04% to $17.1. The company's market cap stands at $846.8 million. As per the news, the Q1 earnings report came out today.
- AquaBounty Techs (NASDAQ:AQB) shares fell 10.18% to $0.66. The company's market cap stands at $2.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.